Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Unknown 2Not yet recruiting 2

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Carcinoma, Hepatocellular 41Stomach Neoplasms 22Esophageal Neoplasms 20Esophageal Squamous Cell Carcinoma 19Colorectal Neoplasms 12Pancreatic Neoplasms 9Liver Neoplasms 6Cholangiocarcinoma 6Biliary Tract Neoplasms 5Advanced Gastric Cancer 5Locally Advanced Gastric Cancer 4Rectal Neoplasms 3Neoplasms 2Neoplasm Metastasis 2Metastatic Gastric Adenocarcinoma 2Locally Advanced Rectal Cancer 2Liver Diseases 2Gastrointestinal Neoplasms 2Esophageal Diseases 2Digestive System Neoplasms 2Colonic Neoplasms 2Advanced Gastric Adenocarcinoma 2Unresectable Gallbladder Cancer 1Turcot syndrome 1Stomach Diseases 1Stage IV Gastric Cancer With Metastasis 1Second Line Treatment of Gastric Cancer 1SHR-1210 1Recurrence 1Rectal Cancer Patients 1

Interventions

camrelizumab 4Oxaliplatin 3apatinib 2S 1 (combination) 2Capecitabine 2XELOX 1Taxes 1Surgical Procedures, Operative 1Nivolumab 1Laparoscopy 1Hyperthermic Intraperitoneal Chemotherapy 1Gastrectomy 1Conversion to Open Surgery 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Locally Advanced Gastric Cancer × camrelizumab × Gastrointestinal × Clear all
NCT06235164 2024-01-31

The Safety and Efficacy of Neoadjuvant Immunochemotherapy Followed by Laparoscopic Gastrectomy for Gastric Cancer

Fujian Medical University

Unknown
585 enrolled
Gastrointestinal

Locally Advanced Gastric Cancer

NCT05610332 2022-11-09

Clinical Efficacy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Immunotypes

Fujian Medical University

Phase 3 Not yet recruiting
216 enrolled
Gastrointestinal

Locally Advanced Gastric Cancer

NCT05545436 2022-09-22

Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer

Third Affiliated Hospital, Sun Yat-Sen University

Phase 2 Unknown
34 enrolled
Gastrointestinal

Locally Advanced Gastric Cancer

NCT05524974 2022-09-01

Clinical Study of Camrelizumab, Apatinib Mesylate and Nab-paclitaxel Combined With Oxplatin and S-1 in the Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Genotypes

Fujian Medical University

Phase 2 Not yet recruiting
203 enrolled
Gastrointestinal

Locally Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡